Form 4: SpringWorks Therapeutics Chief Scientific Officer Sells Shares to Cover Tax Obligations

SpringWorks Therapeutics' Chief Scientific Officer, Tai-An Lin, disposed of 855 shares to cover tax obligations related to vesting restricted stock units.

Summary

• Tai-An Lin, the Chief Scientific Officer of SpringWorks Therapeutics, disposed of 855 shares of common stock on January 4, 2025.
• The shares were sold at a price of $38.19 per share.
• This transaction was not a direct sale by Mr. Lin, but rather shares withheld by the company to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Lin beneficially owns 26,110 shares of SpringWorks Therapeutics stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Similar transactions are common across the pharmaceutical and biotech industry where stock-based compensation is a significant part of executive pay.
• Many companies use a similar approach of withholding shares to cover tax obligations when restricted stock units vest.
• This type of transaction is not unusual and is generally viewed as a normal part of executive compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine tax-related sale.

Key Dates

Keywords

SpringWorks Therapeutics, insider trading, Form 4, stock sale, restricted stock units, tax obligations, Tai-An Lin, SWTX